From multi-omics screening to functional validation: The SOD1-SIRT5 Axis as a potential mediator of ammonia-related neuronal injury and NAD⁺-based neuroprotection in epilepsy

Jing Han, Ya Huang, Sijun Li, Caixia Xuan, Peiying Qin, Tingzhi Liu, Chunxiang Jiang, Xinhong Liang, Tingting Tan, Xing Wei, Chaoning Liu

Open source

DOI
10.1007/s11011-026-02016-2
Published
2026-11-04
Container
Metabolic Brain Disease
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11011-026-02016-2,
  title = {From multi-omics screening to functional validation: The SOD1-SIRT5 Axis as a potential mediator of ammonia-related neuronal injury and NAD⁺-based neuroprotection in epilepsy},
  author = {Jing Han and Ya Huang and Sijun Li and Caixia Xuan and Peiying Qin and Tingzhi Liu and Chunxiang Jiang and Xinhong Liang and Tingting Tan and Xing Wei and Chaoning Liu},
  year = {2026},
  journal = {Metabolic Brain Disease},
  doi = {10.1007/s11011-026-02016-2},
  url = {https://doi.org/10.1007/s11011-026-02016-2}
}

RIS

TY  - JOUR
TI  - From multi-omics screening to functional validation: The SOD1-SIRT5 Axis as a potential mediator of ammonia-related neuronal injury and NAD⁺-based neuroprotection in epilepsy
AU  - Jing Han
AU  - Ya Huang
AU  - Sijun Li
AU  - Caixia Xuan
AU  - Peiying Qin
AU  - Tingzhi Liu
AU  - Chunxiang Jiang
AU  - Xinhong Liang
AU  - Tingting Tan
AU  - Xing Wei
AU  - Chaoning Liu
PY  - 2026
JO  - Metabolic Brain Disease
DO  - 10.1007/s11011-026-02016-2
UR  - https://doi.org/10.1007/s11011-026-02016-2
ER  - 

APA

Han, J., Huang, Y., Li, S., Xuan, C., Qin, P., Liu, T., Jiang, C., Liang, X., Tan, T., Wei, X., & Liu, C. (2026). From multi-omics screening to functional validation: The SOD1-SIRT5 Axis as a potential mediator of ammonia-related neuronal injury and NAD⁺-based neuroprotection in epilepsy. Metabolic Brain Disease. https://doi.org/10.1007/s11011-026-02016-2

Source records